Title : Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors - Davidson_2010_Mayo.Clin.Proc_85_S27 |
Author(s) : Davidson JA |
Ref : Mayo Clin Proc , 85 :S27 , 2010 |
Abstract : Davidson_2010_Mayo.Clin.Proc_85_S27 |
ESTHER : Davidson_2010_Mayo.Clin.Proc_85_S27 |
PubMedSearch : Davidson_2010_Mayo.Clin.Proc_85_S27 |
PubMedID: 21106865 |
Title : Advances in therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors - Davidson_2009_Cleve.Clin.J.Med_76 Suppl 5_S28 |
Author(s) : Davidson JA |
Ref : Cleve Clin J Med , 76 Suppl 5 :S28 , 2009 |
Abstract : Davidson_2009_Cleve.Clin.J.Med_76 Suppl 5_S28 |
ESTHER : Davidson_2009_Cleve.Clin.J.Med_76 Suppl 5_S28 |
PubMedSearch : Davidson_2009_Cleve.Clin.J.Med_76 Suppl 5_S28 |
PubMedID: 19952301 |